Blocking Tim-3 signaling also increased the proliferation of tumor-infiltrating T cells in HBV-associated HCC patients, and the number of Tim-3+ tumor-infiltrating cells was negatively link with patients’ survival [111]. Here, HAVCR2 is linked to neoplasm.